Biochemical Insights and Clinical Applications of Ischemia-Modified Albumin in Ischemic Conditions

July 2024 in “ Journal of Vascular Diseases ”

S. P. N. N. Senadeera, C. B. Ranaweera, Inoka C. Perera, Darshana Kottahachchi

We don't know much about this study yet.

We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.

View this study on mdpi.com →

Discuss this study in the Community →

Research cited in this study

2 / 2 results

research Ischemia-Modified Albumin: A Potential New Marker of Oxidative Stress in Dermatological Diseases

6 citations , May 2022 in “Medicina-lithuania”

IMA may indicate oxidative stress in skin and hair disorders, but more research is needed.

research Ischemia-Modified Albumin as a Possible Marker of Oxidative Stress in Patients with Telogen Effluvium

8 citations , May 2020 in “Anais Brasileiros de Dermatologia”

Higher levels of ischemia-modified albumin in telogen effluvium patients may indicate oxidative stress.

Related Research

1 / 1 results

research The Role of Ischemia-Modified Albumin and Ischemia-Modified Albumin to Albumin Ratios in Patients with Alopecia Areata

3 citations , January 2023 in “Dermatology Practical & Conceptual”

IMA and IMA/albumin levels don't predict alopecia areata severity.